Western Europe Consumer Health Market: UK Adds the Most New Sales, Boosted by Self-Medication and Rx-to-OTC Switches
April 23, 2024 04:28 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Consumer Health in Western Europe" report has been added to ResearchAndMarkets.com's offering. While coughs, colds and the flu were less prevalent...
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
April 18, 2024 16:05 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD)...
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
April 18, 2024 07:30 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and
Investigator-Initiated Pre-Clinical Studies at ESCMID Global (Formerly ECCMID)
Q1 2024 Revenue and Business Update
April 17, 2024 03:05 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the...
Astaxanthin Market size worth $ 92.81 Billion, Globally, by 2031 at 2.38% CAGR – Report By Verified Market Research®
April 16, 2024 10:15 ET
|
Verified Market Research
Jersey City, New Jersey, April 16, 2024 (GLOBE NEWSWIRE) -- The Global Astaxanthin Market is projected to grow at a CAGR of 2.38% from 2024 to 2031, according to a new report published by Verified...
QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
April 16, 2024 08:30 ET
|
QSAM Biosciences Inc.
Austin, TX, April 16, 2024 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc. (OTCQB: QSAM) (“QSAM” or the “Company”) previously announced that it will effectuate a reverse stock split of the issued and...
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
April 15, 2024 18:27 ET
|
Telix Pharmaceuticals Limited
FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imagingCollaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as...
Asia Pharmaceutical Directory 2024: Top Source of Information on 10,000 Pharmaceutical and Biotechnology Companies
April 15, 2024 11:19 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Asian Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.Keep up-to-date with the Asian Pharmaceutical...
Global Pharma Handbook 2024: Expanded Coverage of Health Systems, Sales, Demand Profiles, Clinical Trials, Drug Approval Procedures, Regulatory Policies, IP, Pricing, Marketing, Generics
April 15, 2024 09:06 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Pharma Handbook 2024" directory has been added to ResearchAndMarkets.com's offering.The Global Pharma Handbook includes expanded coverage of...
European and USA Pharmaceutical Directory 2024: Indispensable Guide for Key Decision-makers
April 15, 2024 09:04 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "European and USA Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.The European & USA Pharmaceutical...